Skip to main content

Advertisement

SpringerLink
Log in

Induction of remission following a single dose of rituximab alone in a patient with minimal change nephrotic syndrome

  • Case Report
  • Published:
Clinical and Experimental Nephrology Aims and scope Submit manuscript

Abstract

Treatment with a single dose of rituximab alone induced remission in a patient with relapsed minimal change nephrotic syndrome (MCNS). A 27-year-old man was given corticosteroid (prednisolone; PSL) and cyclosporine (CyA) therapy combined with rituximab for his fifth relapse in 2008. Thereafter, complete remission was achieved and maintained despite eventual discontinuation of the PSL and CyA. In 2010, we treated his sixth relapse with a single dose of rituximab. Complete remission was obtained 32 days later. This is the first report of rituximab monotherapy in the treatment of MCNS.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Cunard R, Kelly CJ. T cells and minimal change disease. J Am Soc Nephrol. 2002;13:1409–11.

    Article  PubMed  Google Scholar 

  2. François H, Daugas E, Bensman A, Ronco P. Unexpected efficacy of rituximab in multirelapsing minimal change nephrotic syndrome in the adult: first case report and pathophysiological considerations. Am J Kidney Dis. 2006;49(1):158–61.

    Article  Google Scholar 

  3. Sawara Y, Itabashi M, Kojima C, Tabata H, Kamei D, Kawanishi K, et al. Successful therapeutic use of a single-dose of rituximab on relapse in adults with minimal change nephritic syndrome. Clin Nephrol. 2009;72:69–72.

    PubMed  CAS  Google Scholar 

  4. Benz K, Dotsch J, Rascher W, Stachel D. Change of the course of steroid-dependent nephrotic syndrome after rituximab therapy. Pediatr Nephrol. 2004;19:794–7.

    Article  PubMed  Google Scholar 

  5. Pescoviz MD, Book BK, Sider RA. Resolution of recurrent focal segmental glomerulosclerosis proteinuria after rituximab treatment. N Engl J Med. 2006;354:1961–3.

    Article  Google Scholar 

  6. Gilbert RD, Hulse E, Rigden S. Rituximab therapy for steroid-dependent minimal change nephrotic syndrome. Pediatr Nephrol. 2006;21:1698–700.

    Article  PubMed  Google Scholar 

  7. Smith GC. Is there a role for rituximab in the treatment of idiopathic childhood nephrotic syndrome? Pediatr Nephrol. 2007;22:893–8.

    Article  PubMed  Google Scholar 

  8. Guigonis V, Dallocchio A, Baudouin V, Dehennault M, Hachon-Le Camus C, Afanetti M, et al. Rituximab treatment for severe steroid- or cyclosporine-dependent nephrotic syndrome: a multicentric series of 22 cases. Pediatr Nephrol. 2008;23:1269–79.

    Article  PubMed  Google Scholar 

  9. Mansour H, Cheval L, Elalouf JM, Aude JC, Alyanakian MA, Mougenot B, et al. T-cell transcriptome analysis points up a thymic disorder in idiopathic nephrotic syndrome. Kidney Int. 2005;67:2168–77.

    Article  PubMed  CAS  Google Scholar 

  10. Yap HK, Cheung W, Murugasu B, Sim SK, Seah CC, Jordan SC. Th1 and Th2 cytokine mRNA profiles in childhood nephrotic syndrome: evidence for increased IL-13 mRNA expression in relapse. J Am Soc Nephrol. 1999;10:529–37.

    PubMed  CAS  Google Scholar 

  11. Johnson RJ, Hurtado A, Merszei J, Rodriguez-Iturbe B, Feng L. Hypothesis: dysregulation of immunologic balance resulting from hygiene and socioeconomic factors may influence the epidemiology and cause of glomerulonephritis worldwide. Am J Kidney Dis. 2003;42:575–81.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medicine, Kidney Center, Tokyo Women’s Medical University, 8-1 Kawada-cho, Shinjuku-ku, Tokyo, 162-8666, Japan

    Nobuyuki Amemiya, Takashi Takei, Chiari Kojima, Hirohiko Nokiba, Mitsuyo Itabashi & Kosaku Nitta

Authors
  1. Nobuyuki Amemiya
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Takashi Takei
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Chiari Kojima
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Hirohiko Nokiba
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Mitsuyo Itabashi
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Kosaku Nitta
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Takashi Takei.

About this article

Cite this article

Amemiya, N., Takei, T., Kojima, C. et al. Induction of remission following a single dose of rituximab alone in a patient with minimal change nephrotic syndrome. Clin Exp Nephrol 15, 933–936 (2011). https://doi.org/10.1007/s10157-011-0510-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10157-011-0510-5

Keywords

Search

Navigation